Taken together, these findings suggest that ischemic heart disease drives a broad depletion of CD4+ cells, weakening the adaptive immune repertoire, while end-stage heart failure is associated with preserved CD4+ numbers but selective enrichment of CCR5+CXCR3+ inflammatory subsets. The gene discussed is CCR5; the disease is coronary artery disorder.